PWMG
AGN

Prestige Wealth Management Group’s Allergan plc AGN Stock Holding History

Prestige Wealth Management Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-171
Closed -$31K – 998
2020
Q1 		$31K Buy
171
+21
+14% +$3.95K 0.01% 227
2019
Q4 		$29K Hold
150
– – 0.02% 250
2019
Q3 		$25K Hold
150
– – 0.01% 255
2019
Q2 		$25K Hold
150
– – 0.02% 247
2019
Q1 		$22K Sell
150
-14
-9% -$2.03K 0.01% 269
2018
Q4 		$22K Buy
+164
New +$26.9K 0.02% 293

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Prestige Wealth Management Group's AGN Position: Q2 2020 in Review

Prestige Wealth Management Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 171 shares — an estimated $31K sold.

Prestige Wealth Management Group first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $31K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Prestige Wealth Management Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Prestige Wealth Management Group sold 171 Allergan plc shares in Q2 2020, an estimated $31K.
  • Prestige Wealth Management Group first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Prestige Wealth Management Group's Allergan plc position peaked at $31K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Prestige Wealth Management Group's 13F filing for Q2 2020, filed 13 Aug 2020.